术中磁共振成像辅助下显微镜和经鼻内镜经蝶窦微创手术切除侵袭性较小的垂体腺瘤后肿瘤残余的特征。

Characterization of tumor remnants in intraoperative MRI-assisted microscopic and endoscopic transsphenoidal resection of less invasive pituitary adenomas.

机构信息

Department of Neurosurgery, University of Ulm, Ludwig-Heilmeyerstr, 2, 89312, Günzburg, Germany.

Endokrinologiezentrum Ulm, Bahnhofplatz 7, 89073, Ulm, Germany.

出版信息

Neurosurg Rev. 2022 Apr;45(2):1701-1708. doi: 10.1007/s10143-021-01705-z. Epub 2021 Dec 2.

Abstract

INTRODUCTION

Intraoperative magnetic resonance imaging (iMRI) improves the intraoperative detection of adenoma remnants in transsphenoidal surgery. iMRI might be redundant in endoscopic pituitary surgery in non-invasive tumors (Knosp 0-2) due to a superior visualization of anatomical structures in the periphery of the sella turcica compared to the microscopic technique. We identified the anatomical location of tumor remnants in iMRI and evaluated risk factors for secondary resection after iMRI and hereby selected patients with pituitary adenomas who may benefit from iMRI-assisted resection.

METHODS

We conducted a retrospective monocenter study of patients who underwent iMRI-assisted transsphenoidal surgical resection of pituitary adenomas at our department between 2012 and 2020. A total number of 190 consecutive iMRI-assisted transsphenoidal surgeries of pituitary adenomas graded as Knosp 0-2 were selected for analysis. Exclusion criteria were missing iMRI availability or pathologies other than adenomas. Of these 190 cases, 46.3% (N = 88) were treated with microscopic, 48.4% (N = 92) with endoscopic, and 5.3% (N = 10) with endoscopic-assisted technique. Volumetric measurement of preoperative, intraoperative, and postoperative tumor extension was performed. Demographic data, tumor characteristics, and MRI features were evaluated. Additionally, analysis of adenoma remnants identified by iMRI was performed.

RESULTS

An additional resection after iMRI was performed in 16.3% (N = 31). iMRI helped to reach gross total resection (GTR) in 83.9% (26/31) of these cases. False-positive resection was found in 1 patient (0.5%). Multivariable logistic analysis identified tumor volume (OR = 1.2, p = 0.007) recurrence (OR = 11.3, p = 0.002) and microscopic technique (OR = 2.8, p = 0.029) as independent risk factors for additional resection. Simultaneously, the endoscopic technique was significantly associated with GTR as evaluated by iMRI (OR = 2.8, p = 0.011) and postoperative MRI (OR = 5.8, p = 0.027). The detailed analysis of adenoma remnants on iMRI revealed the suprasellar location in a diaphragm fold, penetrating tumor above the diaphragm, or undetected invasion of cavernous sinus as well as in case of microscopic resection tumor location outside the line of sight as the main reasons for incomplete resections.

CONCLUSION

Tumor volume, recurrence, and microscopic technique were identified as independent predictors for additional resection in patients with Knosp 0-2 adenomas. iMRI might increase the extent of resection (EOR) safely even after the endoscopic visualization of the sella with very low risk for false-positive findings. Remnants of tumors hidden within the diaphragmic folds, intrathecally, or behind the infiltrated wall of cavernous sinus not recognized on preoperative MRI were the most common findings in iMRI.

摘要

简介

术中磁共振成像(iMRI)可提高经蝶窦手术中对腺瘤残留的术中检测。由于与显微镜技术相比,iMRI 可以更好地显示鞍旁结构,因此在非侵袭性肿瘤(Knosp 0-2)的内镜垂体手术中,iMRI 可能会显得多余。我们确定了 iMRI 中肿瘤残留的解剖位置,并评估了 iMRI 后二次切除的危险因素,从而选择可能受益于 iMRI 辅助切除的垂体腺瘤患者。

方法

我们对 2012 年至 2020 年期间在我科行 iMRI 辅助经蝶窦垂体腺瘤切除术的患者进行了回顾性单中心研究。共选择了 190 例连续接受 iMRI 辅助经蝶窦垂体腺瘤 Knosp 0-2 分级的患者进行分析。排除标准为 iMRI 可用性缺失或除腺瘤以外的其他病理。在这 190 例中,46.3%(N=88)采用显微镜治疗,48.4%(N=92)采用内镜治疗,5.3%(N=10)采用内镜辅助技术治疗。对术前、术中、术后肿瘤延伸进行容积测量。评估了人口统计学数据、肿瘤特征和 MRI 特征。此外,还对 iMRI 识别的腺瘤残留进行了分析。

结果

16.3%(N=31)的患者在 iMRI 后进行了额外的切除。在这些病例中,iMRI 帮助 83.9%(26/31)达到大体全切除(GTR)。1 例(0.5%)发现假阳性切除。多变量逻辑分析发现肿瘤体积(OR=1.2,p=0.007)、复发(OR=11.3,p=0.002)和显微镜技术(OR=2.8,p=0.029)是额外切除的独立危险因素。同时,内镜技术与 iMRI 评估的 GTR(OR=2.8,p=0.011)和术后 MRI(OR=5.8,p=0.027)显著相关。iMRI 上腺瘤残留的详细分析显示,在膈褶上方的鞍上位置、穿透膈上方的肿瘤或未检测到海绵窦侵袭,以及显微镜切除时肿瘤位置超出视线,是不完全切除的主要原因。

结论

Knosp 0-2 腺瘤患者的肿瘤体积、复发和显微镜技术被确定为额外切除的独立预测因素。即使在经蝶窦显微镜可视化后,iMRI 仍可安全地提高切除范围(EOR),并且假阳性发现的风险非常低。术前 MRI 未识别的隐藏在膈褶内、椎管内或浸润性海绵窦壁后的肿瘤残留是 iMRI 中最常见的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b12a/8976794/11582aa44b2e/10143_2021_1705_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索